Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PLAGL1
|
ENSG00000118495.14 | PLAG1 like zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PLAGL1 | hg19_v2_chr6_-_144385698_144385742 | 0.18 | 3.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51472031 | 7.80 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr19_-_51504852 | 6.53 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
chr18_+_33877654 | 6.13 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr19_-_51472222 | 5.88 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
chr2_-_241396131 | 5.82 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
chr19_-_55658687 | 5.77 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr22_+_38071615 | 5.50 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
chr19_+_35645817 | 5.29 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr13_-_20806440 | 5.16 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
chr2_-_1748214 | 5.07 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr8_+_22022800 | 5.02 |
ENST00000397814.3
|
BMP1
|
bone morphogenetic protein 1 |
chr19_-_51014460 | 4.95 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
chr17_-_76899275 | 4.85 |
ENST00000322630.2
ENST00000586713.1 |
DDC8
|
Protein DDC8 homolog |
chr1_-_17307173 | 4.82 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
chr4_-_103266355 | 4.81 |
ENST00000424970.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr1_-_20812690 | 4.81 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr19_-_51014345 | 4.67 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
chr19_-_19051103 | 4.52 |
ENST00000542541.2
ENST00000433218.2 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr9_+_131182697 | 4.47 |
ENST00000372838.4
ENST00000411852.1 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
chr19_-_55658281 | 4.45 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr4_+_4388805 | 4.30 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr19_-_1513188 | 4.26 |
ENST00000330475.4
|
ADAMTSL5
|
ADAMTS-like 5 |
chr19_-_51471381 | 4.18 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr8_-_23261589 | 4.15 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
chr9_+_128509663 | 4.14 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr13_+_110959598 | 4.07 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr22_+_31489344 | 4.05 |
ENST00000404574.1
|
SMTN
|
smoothelin |
chr19_-_19051993 | 3.89 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr19_-_51487071 | 3.80 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr1_-_205419053 | 3.78 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
chr1_+_32042131 | 3.78 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr22_-_37640456 | 3.72 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr10_-_75634219 | 3.71 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr11_-_2906979 | 3.70 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr16_-_56459354 | 3.69 |
ENST00000290649.5
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase |
chr9_-_136344197 | 3.67 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr19_+_2249308 | 3.66 |
ENST00000592877.1
ENST00000221496.4 |
AMH
|
anti-Mullerian hormone |
chr11_+_69924639 | 3.64 |
ENST00000538023.1
ENST00000398543.2 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr2_+_95691445 | 3.62 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
chr20_-_23030296 | 3.60 |
ENST00000377103.2
|
THBD
|
thrombomodulin |
chr1_+_155178481 | 3.58 |
ENST00000368376.3
|
MTX1
|
metaxin 1 |
chr8_+_86376081 | 3.58 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
chr9_-_19127474 | 3.58 |
ENST00000380465.3
ENST00000380464.3 ENST00000411567.1 ENST00000276914.2 |
PLIN2
|
perilipin 2 |
chr21_+_45161301 | 3.56 |
ENST00000467908.1
|
PDXK
|
pyridoxal (pyridoxine, vitamin B6) kinase |
chr1_-_17304771 | 3.55 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chr1_+_32042105 | 3.53 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr16_-_85784718 | 3.53 |
ENST00000602766.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
chr15_-_74501360 | 3.52 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
chr9_+_128509624 | 3.51 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr16_-_85784557 | 3.49 |
ENST00000602675.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
chr2_-_72375167 | 3.47 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr1_+_150480576 | 3.46 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
chr2_-_216300784 | 3.45 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr16_+_66638616 | 3.41 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr16_+_66638567 | 3.38 |
ENST00000567572.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr20_-_56284816 | 3.36 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr10_-_17659234 | 3.34 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr14_-_75079026 | 3.34 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
chr2_-_241396106 | 3.34 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
chr4_-_103266626 | 3.27 |
ENST00000356736.4
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr16_-_85784634 | 3.27 |
ENST00000284245.4
ENST00000602914.1 |
C16orf74
|
chromosome 16 open reading frame 74 |
chr6_+_151662815 | 3.26 |
ENST00000359755.5
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr15_-_74495188 | 3.25 |
ENST00000563965.1
ENST00000395105.4 |
STRA6
|
stimulated by retinoic acid 6 |
chr19_-_51017881 | 3.22 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
chr20_-_52790512 | 3.21 |
ENST00000216862.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
chr1_+_150522222 | 3.19 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
chr1_+_155178518 | 3.18 |
ENST00000316721.4
|
MTX1
|
metaxin 1 |
chr19_+_35645618 | 3.17 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr19_-_51466681 | 3.17 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr15_-_34659349 | 3.15 |
ENST00000314891.6
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
chr19_-_19051927 | 3.14 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
chr2_-_10220538 | 3.12 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
chr12_+_53491220 | 3.10 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
chr19_+_676385 | 3.09 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
chr9_+_139560197 | 3.07 |
ENST00000371698.3
|
EGFL7
|
EGF-like-domain, multiple 7 |
chr19_-_51472823 | 3.07 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr15_-_90039805 | 3.06 |
ENST00000544600.1
ENST00000268122.4 |
RHCG
|
Rh family, C glycoprotein |
chr6_+_151561506 | 3.04 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr7_-_38407770 | 3.03 |
ENST00000390348.2
|
TRGV1
|
T cell receptor gamma variable 1 (non-functional) |
chr1_+_150480551 | 3.02 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
chr4_-_57522470 | 3.02 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
chr19_+_45349432 | 3.00 |
ENST00000252485.4
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
chr19_-_51504411 | 2.93 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
chr19_-_51456321 | 2.93 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr10_+_124221036 | 2.93 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr4_-_57522598 | 2.92 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr9_-_123639304 | 2.91 |
ENST00000436309.1
|
PHF19
|
PHD finger protein 19 |
chr12_+_119616447 | 2.88 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
chr17_-_73840415 | 2.87 |
ENST00000592386.1
ENST00000412096.2 ENST00000586147.1 |
UNC13D
|
unc-13 homolog D (C. elegans) |
chr7_-_24797546 | 2.86 |
ENST00000414428.1
ENST00000419307.1 ENST00000342947.3 |
DFNA5
|
deafness, autosomal dominant 5 |
chr8_-_144655141 | 2.85 |
ENST00000398882.3
|
MROH6
|
maestro heat-like repeat family member 6 |
chr19_-_51471362 | 2.83 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
chr5_-_127873659 | 2.83 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
chr19_-_55658650 | 2.82 |
ENST00000589226.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr1_+_17559776 | 2.81 |
ENST00000537499.1
ENST00000413717.2 ENST00000536552.1 |
PADI1
|
peptidyl arginine deiminase, type I |
chr1_-_228603694 | 2.77 |
ENST00000366697.2
|
TRIM17
|
tripartite motif containing 17 |
chr19_-_15344243 | 2.76 |
ENST00000602233.1
|
EPHX3
|
epoxide hydrolase 3 |
chr20_-_43280361 | 2.76 |
ENST00000372874.4
|
ADA
|
adenosine deaminase |
chr9_+_139557360 | 2.76 |
ENST00000308874.7
ENST00000406555.3 ENST00000492862.2 |
EGFL7
|
EGF-like-domain, multiple 7 |
chr10_+_75670862 | 2.76 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
chr19_-_42927251 | 2.76 |
ENST00000597001.1
|
LIPE
|
lipase, hormone-sensitive |
chr1_-_6557441 | 2.75 |
ENST00000400915.3
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr17_-_76921459 | 2.73 |
ENST00000262768.7
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr11_-_2160611 | 2.72 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr10_-_75634260 | 2.71 |
ENST00000372765.1
ENST00000351293.3 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr11_+_844067 | 2.71 |
ENST00000397406.1
ENST00000409543.2 ENST00000525201.1 |
TSPAN4
|
tetraspanin 4 |
chr19_-_51456344 | 2.67 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr20_+_306177 | 2.66 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr19_+_45418067 | 2.65 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
chr20_-_60942361 | 2.64 |
ENST00000252999.3
|
LAMA5
|
laminin, alpha 5 |
chr11_-_568369 | 2.62 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
chr11_+_69931519 | 2.61 |
ENST00000316296.5
ENST00000530676.1 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr7_-_143059780 | 2.61 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
chr3_+_136537911 | 2.61 |
ENST00000393079.3
|
SLC35G2
|
solute carrier family 35, member G2 |
chr19_+_45281118 | 2.59 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr12_+_57522258 | 2.58 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr20_+_62327996 | 2.57 |
ENST00000369996.1
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy |
chr19_+_1450112 | 2.55 |
ENST00000590469.1
ENST00000233607.2 ENST00000238483.4 ENST00000590877.1 |
APC2
|
adenomatosis polyposis coli 2 |
chr5_-_168727713 | 2.54 |
ENST00000404867.3
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr20_-_52790055 | 2.54 |
ENST00000395955.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
chr9_+_33750667 | 2.54 |
ENST00000457896.1
ENST00000342836.4 ENST00000429677.3 |
PRSS3
|
protease, serine, 3 |
chr22_-_37640277 | 2.52 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr19_-_51487282 | 2.52 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr9_+_33750515 | 2.51 |
ENST00000361005.5
|
PRSS3
|
protease, serine, 3 |
chr18_+_56530136 | 2.51 |
ENST00000591083.1
|
ZNF532
|
zinc finger protein 532 |
chrX_+_134555863 | 2.51 |
ENST00000417443.2
|
LINC00086
|
long intergenic non-protein coding RNA 86 |
chr7_-_143059845 | 2.51 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
chr1_+_17531614 | 2.50 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
chr22_-_19137796 | 2.49 |
ENST00000086933.2
|
GSC2
|
goosecoid homeobox 2 |
chr3_-_52567792 | 2.48 |
ENST00000307092.4
ENST00000422318.2 ENST00000459839.1 |
NT5DC2
|
5'-nucleotidase domain containing 2 |
chr9_-_136344237 | 2.47 |
ENST00000432868.1
ENST00000371899.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr11_-_123065989 | 2.46 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
chr16_+_640201 | 2.45 |
ENST00000563109.1
|
RAB40C
|
RAB40C, member RAS oncogene family |
chr4_+_156680518 | 2.45 |
ENST00000513437.1
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
chr17_-_71410794 | 2.44 |
ENST00000424778.1
|
SDK2
|
sidekick cell adhesion molecule 2 |
chr5_+_135364584 | 2.43 |
ENST00000442011.2
ENST00000305126.8 |
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr4_-_103266219 | 2.43 |
ENST00000394833.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr21_-_44496441 | 2.43 |
ENST00000359624.3
ENST00000352178.5 |
CBS
|
cystathionine-beta-synthase |
chr21_-_44846999 | 2.43 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
chr9_-_123639445 | 2.42 |
ENST00000312189.6
|
PHF19
|
PHD finger protein 19 |
chr22_+_25003626 | 2.42 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
chr2_+_33172221 | 2.42 |
ENST00000354476.3
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr19_-_51014588 | 2.42 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
chr3_-_48594248 | 2.38 |
ENST00000545984.1
ENST00000232375.3 ENST00000416568.1 ENST00000383734.2 ENST00000541519.1 ENST00000412035.1 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
chr8_+_22022653 | 2.38 |
ENST00000354870.5
ENST00000397816.3 ENST00000306349.8 |
BMP1
|
bone morphogenetic protein 1 |
chr11_+_842808 | 2.37 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
chr19_-_14629224 | 2.37 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr19_-_51512804 | 2.37 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
chr6_-_4135693 | 2.36 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr6_+_34204642 | 2.36 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
chr6_+_31371337 | 2.34 |
ENST00000449934.2
ENST00000421350.1 |
MICA
|
MHC class I polypeptide-related sequence A |
chr5_-_132112921 | 2.33 |
ENST00000378721.4
ENST00000378701.1 |
SEPT8
|
septin 8 |
chr2_-_110371412 | 2.32 |
ENST00000415095.1
ENST00000334001.6 ENST00000437928.1 ENST00000493445.1 ENST00000397714.2 ENST00000461295.1 |
SEPT10
|
septin 10 |
chr1_-_6545502 | 2.32 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chrX_-_48328631 | 2.31 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
chr17_+_6544356 | 2.30 |
ENST00000574838.1
|
TXNDC17
|
thioredoxin domain containing 17 |
chrX_-_153881842 | 2.30 |
ENST00000369585.3
ENST00000247306.4 |
CTAG2
|
cancer/testis antigen 2 |
chr1_-_204121013 | 2.29 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
chr12_-_47473707 | 2.28 |
ENST00000429635.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
chr15_+_90728145 | 2.27 |
ENST00000561085.1
ENST00000379122.3 ENST00000332496.6 |
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr1_-_6321035 | 2.27 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
chr4_-_175443484 | 2.27 |
ENST00000514584.1
ENST00000542498.1 ENST00000296521.7 ENST00000422112.2 ENST00000504433.1 |
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
chr7_-_93519471 | 2.26 |
ENST00000451238.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
chr1_-_204121102 | 2.25 |
ENST00000367202.4
|
ETNK2
|
ethanolamine kinase 2 |
chr1_-_6546001 | 2.25 |
ENST00000400913.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr2_-_235405679 | 2.23 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr11_+_844406 | 2.23 |
ENST00000397404.1
|
TSPAN4
|
tetraspanin 4 |
chr11_+_65686952 | 2.22 |
ENST00000527119.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr20_-_43280325 | 2.22 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
chr22_+_51112800 | 2.21 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr10_-_75634326 | 2.20 |
ENST00000322635.3
ENST00000444854.2 ENST00000423381.1 ENST00000322680.3 ENST00000394762.2 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr16_+_66638003 | 2.20 |
ENST00000562357.1
ENST00000360086.4 ENST00000562707.1 ENST00000361909.4 ENST00000460097.1 ENST00000565666.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chrX_-_48328551 | 2.19 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
chr5_-_132112907 | 2.19 |
ENST00000458488.2
|
SEPT8
|
septin 8 |
chr2_+_233925064 | 2.18 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr22_+_23264766 | 2.18 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr2_+_65215604 | 2.18 |
ENST00000531327.1
|
SLC1A4
|
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
chr1_-_6550625 | 2.17 |
ENST00000377725.1
ENST00000340850.5 |
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr1_-_113498616 | 2.17 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
chr1_-_204121298 | 2.16 |
ENST00000367199.2
|
ETNK2
|
ethanolamine kinase 2 |
chr5_-_77944648 | 2.16 |
ENST00000380345.2
|
LHFPL2
|
lipoma HMGIC fusion partner-like 2 |
chr10_+_88728189 | 2.16 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
chr17_+_74380683 | 2.15 |
ENST00000592299.1
ENST00000590959.1 ENST00000323374.4 |
SPHK1
|
sphingosine kinase 1 |
chr22_+_50919995 | 2.14 |
ENST00000362068.2
ENST00000395737.1 |
ADM2
|
adrenomedullin 2 |
chr6_-_30654977 | 2.14 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr17_+_1945301 | 2.10 |
ENST00000572195.1
|
OVCA2
|
ovarian tumor suppressor candidate 2 |
chr9_-_127269661 | 2.09 |
ENST00000373588.4
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
chr9_+_139847347 | 2.09 |
ENST00000371632.3
|
LCN12
|
lipocalin 12 |
chr17_+_7942424 | 2.09 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr17_+_7942335 | 2.09 |
ENST00000380183.4
ENST00000572022.1 ENST00000380173.2 |
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr1_-_204116078 | 2.08 |
ENST00000367198.2
ENST00000452983.1 |
ETNK2
|
ethanolamine kinase 2 |
chrX_+_134166333 | 2.08 |
ENST00000257013.7
|
FAM127A
|
family with sequence similarity 127, member A |
chr16_-_90085824 | 2.07 |
ENST00000002501.6
|
DBNDD1
|
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
chr1_-_93426998 | 2.07 |
ENST00000370310.4
|
FAM69A
|
family with sequence similarity 69, member A |
chr2_-_31361543 | 2.07 |
ENST00000349752.5
|
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
chr19_-_11689752 | 2.05 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr7_-_38370536 | 2.05 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
chr9_-_131644306 | 2.05 |
ENST00000302586.3
|
CCBL1
|
cysteine conjugate-beta lyase, cytoplasmic |
chr1_+_155179012 | 2.05 |
ENST00000609421.1
|
MTX1
|
metaxin 1 |
chr2_-_208031542 | 2.04 |
ENST00000423015.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.5 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
2.2 | 13.5 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
2.0 | 10.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
2.0 | 6.0 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
2.0 | 7.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
2.0 | 2.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.9 | 5.8 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
1.8 | 5.4 | GO:0042938 | dipeptide transport(GO:0042938) |
1.6 | 14.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
1.5 | 4.6 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
1.5 | 4.4 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
1.4 | 5.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
1.4 | 4.1 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
1.3 | 2.6 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
1.3 | 6.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.2 | 8.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.2 | 3.7 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
1.2 | 2.4 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
1.2 | 26.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.2 | 6.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.2 | 3.6 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.2 | 9.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.2 | 3.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.2 | 1.2 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
1.1 | 3.4 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
1.1 | 3.4 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
1.1 | 1.1 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
1.1 | 3.3 | GO:0097187 | dentinogenesis(GO:0097187) |
1.1 | 12.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.1 | 8.9 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
1.1 | 6.5 | GO:0030421 | defecation(GO:0030421) |
1.1 | 3.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
1.0 | 4.0 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
1.0 | 4.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.0 | 8.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.0 | 5.7 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.9 | 3.8 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.9 | 2.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.9 | 2.8 | GO:0035623 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.9 | 2.8 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.9 | 2.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.9 | 10.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.9 | 2.7 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.9 | 8.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.9 | 2.6 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.8 | 4.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 4.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.8 | 2.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.8 | 1.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.8 | 5.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.8 | 1.6 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.8 | 4.1 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.8 | 6.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.8 | 4.8 | GO:0032252 | secretory granule localization(GO:0032252) |
0.8 | 6.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.8 | 3.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.8 | 1.6 | GO:0032196 | transposition(GO:0032196) |
0.8 | 3.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.8 | 2.3 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.8 | 0.8 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.8 | 2.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 0.7 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.7 | 6.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.7 | 0.7 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.7 | 2.2 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.7 | 2.2 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.7 | 0.7 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.7 | 6.3 | GO:0015705 | iodide transport(GO:0015705) |
0.7 | 3.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.7 | 4.2 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 3.5 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.7 | 0.7 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.7 | 10.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.7 | 2.0 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.7 | 0.7 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.7 | 2.0 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.7 | 1.3 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.6 | 2.6 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.6 | 3.9 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.6 | 1.9 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.6 | 2.5 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.6 | 0.6 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.6 | 7.5 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.6 | 7.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 3.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 8.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.6 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.6 | 2.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 11.0 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.6 | 3.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.6 | 1.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.6 | 1.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.6 | 1.8 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.6 | 2.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.6 | 0.6 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.6 | 4.8 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.6 | 1.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.6 | 2.9 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.6 | 2.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.6 | 14.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.6 | 2.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.6 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 0.6 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.6 | 0.6 | GO:0060324 | face development(GO:0060324) |
0.6 | 1.7 | GO:0071790 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.6 | 3.4 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.6 | 1.7 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.6 | 5.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 3.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.6 | 3.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.6 | 1.7 | GO:0002384 | hepatic immune response(GO:0002384) |
0.6 | 3.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.6 | 1.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 0.5 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.5 | 4.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.5 | 2.7 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.5 | 1.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.5 | 2.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.5 | 1.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.5 | 5.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.5 | 2.1 | GO:1901204 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.5 | 2.1 | GO:0007538 | primary sex determination(GO:0007538) |
0.5 | 1.0 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.5 | 1.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 3.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.5 | 1.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.5 | 1.0 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.5 | 4.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.5 | 0.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.5 | 1.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.5 | 2.5 | GO:0060356 | leucine import(GO:0060356) |
0.5 | 2.5 | GO:1990834 | response to odorant(GO:1990834) |
0.5 | 0.5 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
0.5 | 1.5 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.5 | 1.5 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.5 | 2.0 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.5 | 3.0 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.5 | 2.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.5 | 3.0 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 2.5 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.5 | 2.0 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.5 | 1.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 1.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 1.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.5 | 2.9 | GO:0042335 | cuticle development(GO:0042335) |
0.5 | 1.0 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.5 | 10.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.5 | 1.4 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.5 | 0.9 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 1.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.5 | 0.5 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.5 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.5 | 0.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.5 | 2.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 0.9 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
0.5 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 0.9 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.5 | 1.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.8 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.5 | 2.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 3.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.5 | 1.4 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.5 | 3.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.5 | 1.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.5 | 1.4 | GO:0060426 | lung vasculature development(GO:0060426) |
0.4 | 5.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 7.1 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.4 | 0.4 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.4 | 1.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 1.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 4.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.4 | 1.8 | GO:1904647 | response to rotenone(GO:1904647) |
0.4 | 0.4 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.4 | 0.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.4 | 2.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.4 | 0.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.4 | 1.3 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.4 | 1.7 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 5.5 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 1.3 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.4 | 1.7 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.4 | 2.5 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.4 | 1.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) negative regulation of membrane tubulation(GO:1903526) |
0.4 | 2.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.4 | 1.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.4 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.4 | 1.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.8 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.4 | 1.2 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.4 | 2.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.4 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 0.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.4 | 1.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.4 | 1.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.4 | 1.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.4 | 9.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.4 | 2.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 4.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 2.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 11.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 5.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 2.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.4 | 0.8 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.4 | 1.2 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.4 | 1.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.4 | 3.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 2.0 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.4 | 0.8 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.4 | 4.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 9.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.4 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 3.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.4 | 1.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.4 | 1.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.4 | 3.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 1.2 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 5.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.4 | 5.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 3.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.4 | 1.5 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.4 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.4 | 3.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 1.9 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.4 | 1.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 1.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.4 | 1.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 3.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 1.1 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.4 | 1.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 2.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.4 | 4.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 0.4 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.4 | 1.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.4 | 2.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 0.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.4 | 2.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 1.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 4.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.5 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.4 | 1.1 | GO:0030728 | ovulation(GO:0030728) |
0.4 | 1.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.4 | 5.4 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.4 | 0.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.4 | 0.4 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.4 | 2.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 1.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.4 | 1.4 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.4 | 1.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 1.1 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.4 | 2.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.4 | 2.1 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.4 | 0.4 | GO:0001823 | ureteric bud development(GO:0001657) mesonephros development(GO:0001823) |
0.4 | 1.1 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.4 | 1.1 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.3 | 2.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.3 | 0.3 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.3 | 1.0 | GO:0030300 | negative regulation of intestinal phytosterol absorption(GO:0010949) regulation of intestinal cholesterol absorption(GO:0030300) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) regulation of intestinal lipid absorption(GO:1904729) negative regulation of intestinal lipid absorption(GO:1904730) |
0.3 | 1.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.3 | 1.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 1.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.3 | 3.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.7 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
0.3 | 0.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.3 | 1.0 | GO:0050894 | determination of affect(GO:0050894) |
0.3 | 1.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 1.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 4.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 2.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 2.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 0.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 1.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 2.0 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.3 | 1.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 1.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 1.0 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.3 | 0.7 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.3 | 6.8 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.3 | 1.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 1.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 2.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.3 | 1.0 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.3 | 2.3 | GO:0060992 | response to fungicide(GO:0060992) |
0.3 | 1.6 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.3 | 0.3 | GO:0051604 | protein maturation(GO:0051604) |
0.3 | 0.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 1.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 1.9 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.3 | 3.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.6 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.3 | 1.6 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.3 | 2.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 1.9 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.3 | 1.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.3 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.3 | 0.3 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.3 | 0.3 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.3 | 1.2 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.3 | 0.6 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.3 | 1.2 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.9 | GO:0005985 | sucrose metabolic process(GO:0005985) |
0.3 | 0.9 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.3 | 1.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.3 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.3 | 0.6 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.3 | 0.6 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.3 | 0.9 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.3 | 0.6 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.3 | 1.5 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.3 | 0.9 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.3 | 1.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 0.6 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.3 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.6 | GO:0021623 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.3 | 1.5 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.3 | 7.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 0.9 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.3 | 1.2 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.3 | 1.2 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 1.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 3.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.3 | 1.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 1.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 2.7 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.3 | 0.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.3 | 2.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 2.7 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 1.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.3 | 0.3 | GO:0071242 | response to ammonium ion(GO:0060359) cellular response to ammonium ion(GO:0071242) |
0.3 | 9.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 2.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.6 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.3 | 0.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 7.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.6 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.3 | 0.9 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.3 | 4.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 1.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 2.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 1.7 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.3 | 2.3 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 0.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 1.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.3 | 1.1 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.3 | 1.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.3 | 4.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 0.3 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.3 | 1.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.3 | 0.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.3 | 2.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 1.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 1.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.3 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.3 | 1.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 0.3 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.3 | 0.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.3 | 0.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.3 | 0.5 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 1.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.3 | 0.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.3 | 2.2 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.3 | 1.1 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.3 | 1.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.3 | 0.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 0.8 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 1.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.3 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 3.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 2.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 0.3 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.3 | 0.5 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.3 | 9.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.3 | 0.8 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.3 | 0.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
0.3 | 0.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.8 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) cellular response to luteinizing hormone stimulus(GO:0071373) |
0.3 | 1.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 1.8 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.3 | 1.0 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 3.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 0.3 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.3 | 0.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.8 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) |
0.3 | 1.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 8.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 0.8 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.8 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.3 | 0.3 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.3 | 3.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.8 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.3 | 1.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 2.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 1.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 2.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 0.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.8 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
0.3 | 3.0 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.3 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 0.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.3 | 1.0 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.3 | 0.5 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.3 | 2.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 1.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.2 | 3.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 1.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 1.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 2.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 3.4 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.5 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.2 | 1.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 2.4 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 1.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 |